Conclusion: An increasing number of medications did not influence total sleep time but negatively affected the sleep cycle.
several standardized self-administered assessment instruments. For the present study, we examined patients' enhanced sleep assessment findings, as well as those patients' concurrent medications on the day the home sleep study was conducted.
PCS Enhanced Sleep Assessment Measures

Epworth Sleepiness Scale
The Epworth Sleepiness Scale (ESS) consists of 8 questions that ask patients to rate their chance of dozing during specific situations using a 4-point Likert-type scale ranging from 0 ("no chance of dozing") to 3 ("high chance of dozing"). 12 Questions include situations such
as "[s]itting and reading," "[w]atching TV," or "[s]itting
inactive in a public space." Scores of 10 or greater suggest daytime sleepiness.
Pre-Sleep Arousal Scale
The Pre-Sleep Arousal Scale contains 16 questions with response options on a 5-point Likert scale ranging from 1 ("not at all") to 5 ("extremely"). 13 The Pre-Sleep Arousal Scale has 2 subscales-somatic and cognitive.
Somatic questions ask respondents about issues such as "a jittery, nervous feeling in your body," whereas the cognitive questions ask about issues such as "worry "good part of the time," and "most of the time"-scored pair sleep continuity. 6 Tricyclic antidepressants and trazodone increase slow wave sleep and total sleep time, with trazodone also promoting sleep continuity. 7 Antihistamines such as diphenhydramine increase slow wave sleep while also reducing total REM sleep. 5 Some of these same medications also cause nightmares or especially vivid dreams. 8, 9 Multiple sedating medications may also affect respiration during sleep. The PIRS is a 20-item self-report instrument that assesses a person's sleep over the preceding 7-day period. Increasing the number of medications did not significantly alter the amount of time awake, the number of arousals through the night, the total time slept, or sleep latency (P>.05) ( Table 3 ). The number of active medications (ie, 1-6) did not have a statistically significant effect on total sleep time ( Table 4) .
Discussion
Chronic sleep problems can be a frustrating challenge for both the clinician and the patient, particularly when medications, either alone or in combination, do not produce an optimum outcome. Sedative-hypnotic medications may help a person fall asleep and may even promote an inas 1, 2, 3, and 4, respectively. Typical questions on the Zung Self-Rating Depression Scale include "I feel downhearted and blue" and "Morning is when I feel the best."
The Zung Self-Rating Anxiety Scale includes questions such as, "I feel more nervous and anxious than usual"
and "I fall asleep easily and get a good night's rest."
Scores above 50 on the Zung Self-Rating Depression
Scale suggest clinically significant depression, and scores above 45 on the Zung Self-Rating Anxiety Scale suggest clinically significant anxiety.
PCL-M
The PCL-M is a 17-item self-report instrument in which respondents choose among 5 descriptions (ie, "not at all," "a little bit," "moderately," "quite a bit," and "ex- It is important to note that the medications prescribed to the patients in this study are typical for patients with In addition, although we did not exclude any types of medication in our study, the medications of our patient population likely differed from those of other populations. For example, because this study was conducted in a psychiatry unit, it was expected that the participants would be on more psychiatric-type medications. In addition, our population of active-duty service members is young and tends to be healthier than a similar age-matched sample. As such, the patients in our study likely had fewer types of medicine (eg, medication for diabetes mellitus is rare in our patients), which may have led to less confounding variables. Thus, additional research in other patient populations is warranted.
For individuals with chronic insomnia, nonpharmacologic treatment interventions, such as sleep restriction or cognitive behavior therapy, may be useful alternatives. 23 At the very least, the use of evidencedbased nonpharmacologic treatments for insomnia would not increase the potential risks associated with polypharmacy found in this study. 
